TAC1 and astrocytoma (excluding glioblastoma): In astrocytoma cases 2 and 3, a neoadjuvant application of 2 GBq of [213Bi]Bi-DOTA-substance P was given, followed by a necrosectomy, as the only treatment modality; this resulted in very long recurrence-free survival times and an excellent neurological and general condition.